AxoGen Company
Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.
%20.jpg)
.jpg)
Total Funding:
$515.5M
Technology:
Other
Last Funding Type:
Series G
Investors Number:
8
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Estimated Revenue:
$10M to $50M